Literature DB >> 27430236

Neuroprotective Effects of Germinated Brown Rice in Rotenone-Induced Parkinson's-Like Disease Rats.

Supin Chompoopong1, Sunit Jarungjitaree2, Tideeporn Punbanlaem2, Thanaporn Rungruang2, Sukumal Chongthammakun3, Aikkarach Kettawan4, Thongchai Taechowisan5.   

Abstract

The effects of germinated brown rice (GBR) on the motor deficits and the dopaminergic (DA) cell death were investigated in Parkinson's-like disease (PD) rats. Reactive oxidative species generated by chronic subcutaneous injection of rotenone (RT) lead to neuronal apoptosis particularly in the nigrostriatal DA system and produce many features of PD, bradykinesis, postural instability and rigidity. In this study, 4-phenylbutyric acid (4-PBA), previously reported to inhibit RT-induced DA cell death, was used as the positive control. Results show that pretreatment with GBR as well as 4-PBA significantly enhanced the motor activity after RT injection, and GBR affected significantly in open field test, only in the ambulation but not the mobility duration, and ameliorated the time to orient down (t-turn) and total time to descend the pole (t-total) in pole test as compared to RT group, but significantly lowered both t-turn and t-total only in 4-PBA group. The percentage of apoptotic cells in brain measured by flow cytometry and the inflammatory effect measured by ELISA of TNF-α showed significant increase in RT group as compared to the control (CT) group at P < 0.05. Apoptotic cells in RT group (85.98 %) showed a significant (P < 0.05) increase versus CT group (17.50 %), and this effect was attenuated in GBR+RT group by decreasing apoptotic cells (79.32 %), whereas, increased viable cells (17.94 %) versus RT group (10.79 %). GBR in GBR + RT group could decrease TNF-α both in the serum and in brain. In summary, GBR showed a neuroprotective effect in RT-induced PD rats, and it may be useful as a value-added functional food to prevent neurodegenerative disease or PD.

Entities:  

Keywords:  4-phenylbutyrate; Germinated brown rice; Neurodegeneration; Parkinson’s disease; Rotenone

Mesh:

Substances:

Year:  2016        PMID: 27430236     DOI: 10.1007/s12017-016-8427-5

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   3.843


  59 in total

1.  Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes.

Authors:  Umut Ozcan; Erkan Yilmaz; Lale Ozcan; Masato Furuhashi; Eric Vaillancourt; Ross O Smith; Cem Z Görgün; Gökhan S Hotamisligil
Journal:  Science       Date:  2006-08-25       Impact factor: 47.728

2.  Selective vulnerability of dopaminergic neurons to microtubule depolymerization.

Authors:  Yong Ren; Wenhua Liu; Houbo Jiang; Qian Jiang; Jian Feng
Journal:  J Biol Chem       Date:  2005-08-09       Impact factor: 5.157

3.  Mitochondrial function and neurotoxicity.

Authors:  A H Schapira
Journal:  Curr Opin Neurol       Date:  1994-12       Impact factor: 5.710

4.  Sodium 4-phenylbutyrate acts as a chemical chaperone on misfolded myocilin to rescue cells from endoplasmic reticulum stress and apoptosis.

Authors:  Gary Hin-Fai Yam; Katarina Gaplovska-Kysela; Christian Zuber; Jürgen Roth
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-04       Impact factor: 4.799

5.  PARK7 DJ-1 protects against degeneration of nigral dopaminergic neurons in Parkinson's disease rat model.

Authors:  Masatoshi Inden; Takahiro Taira; Yoshihisa Kitamura; Takashi Yanagida; Daiju Tsuchiya; Kazuyuki Takata; Daijiro Yanagisawa; Kaneyasu Nishimura; Takashi Taniguchi; Yoshiaki Kiso; Kanji Yoshimoto; Tomohiro Agatsuma; Shizuyo Koide-Yoshida; Sanae M M Iguchi-Ariga; Shun Shimohama; Hiroyoshi Ariga
Journal:  Neurobiol Dis       Date:  2006-07-24       Impact factor: 5.996

6.  The role of dopamine transporter in selective toxicity of manganese and rotenone.

Authors:  Yoko Hirata; Hiromi Suzuno; Tadamiki Tsuruta; Kentaro Oh-hashi; Kazutoshi Kiuchi
Journal:  Toxicology       Date:  2007-12-03       Impact factor: 4.221

7.  Neurodegeneration of mouse nigrostriatal dopaminergic system induced by repeated oral administration of rotenone is prevented by 4-phenylbutyrate, a chemical chaperone.

Authors:  Masatoshi Inden; Yoshihisa Kitamura; Hiroki Takeuchi; Takashi Yanagida; Kazuyuki Takata; Yuka Kobayashi; Takashi Taniguchi; Kanji Yoshimoto; Masahiko Kaneko; Yasunobu Okuma; Takahiro Taira; Hiroyoshi Ariga; Shun Shimohama
Journal:  J Neurochem       Date:  2007-06       Impact factor: 5.372

8.  A selective toxicity toward cultured mesencephalic dopaminergic neurons is induced by the synergistic effects of energetic metabolism impairment and NMDA receptor activation.

Authors:  I Marey-Semper; M Gelman; M Lévi-Strauss
Journal:  J Neurosci       Date:  1995-09       Impact factor: 6.167

9.  Oral sodium phenylbutyrate therapy in homozygous beta thalassemia: a clinical trial.

Authors:  A F Collins; H A Pearson; P Giardina; K T McDonagh; S W Brusilow; G J Dover
Journal:  Blood       Date:  1995-01-01       Impact factor: 22.113

10.  Effect of different germination conditions on antioxidative properties and bioactive compounds of germinated brown rice.

Authors:  You-Tung Lin; Cheng-Cheng Pao; Shwu-Tzy Wu; Chi-Yue Chang
Journal:  Biomed Res Int       Date:  2015-03-12       Impact factor: 3.411

View more
  3 in total

1.  Acteoside Binds to Caspase-3 and Exerts Neuroprotection in the Rotenone Rat Model of Parkinson's Disease.

Authors:  Jiawen Yuan; Jinpeng Ren; Ying Wang; Xiao He; Yuwu Zhao
Journal:  PLoS One       Date:  2016-09-15       Impact factor: 3.240

2.  Neuroprotective effect of arctigenin against neuroinflammation and oxidative stress induced by rotenone.

Authors:  Na Zhang; Deqiang Dou; Xiaoku Ran; Tingguo Kang
Journal:  RSC Adv       Date:  2018-01-10       Impact factor: 4.036

Review 3.  Natural Products and Their Bioactive Compounds: Neuroprotective Potentials against Neurodegenerative Diseases.

Authors:  Nur Shafika Mohd Sairazi; K N S Sirajudeen
Journal:  Evid Based Complement Alternat Med       Date:  2020-02-14       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.